News/Genomics & Diagnostics Business Review

How Genomics and Diagnostics Companies Are Using Virtual Assistants for Customer Support, Sales Admin, and Coordination

Virtual Assistant News Desk·

The genomics and diagnostics industry has experienced sustained volume growth over the past several years, driven by expanding clinical applications for molecular testing, growing direct-to-consumer genetic testing adoption, and the broader integration of genomic data into oncology, rare disease, and preventive medicine workflows. That growth has created a service and operations scaling challenge that many companies in the space are now addressing through virtual assistant deployment.

Customer Support: Managing Inquiry Volume at Scale

Genomics and diagnostics companies serve a diverse customer base that spans clinical laboratories, hospital systems, physician group practices, research institutions, and individual consumers. Each customer segment generates distinct support needs, from test ordering and insurance pre-authorization questions from clinicians to result interpretation guidance for direct-to-consumer customers, and shipping and sample collection support for research customers.

As testing volumes grow, the volume of inbound customer inquiries grows proportionally — but the nature of most routine inquiries makes them highly suitable for VA-mediated resolution. Order status questions, sample collection kit logistics, billing inquiry routing, portal access support, and test menu information requests are all examples of high-volume inquiries that do not require a licensed scientist or clinical specialist to resolve.

"About 65 percent of our inbound support tickets are order status, kit shipping, or portal access questions," said Sarah Kim, Director of Customer Experience at a next-generation sequencing company based in San Diego. "We trained a team of VAs on our order management system and standard response protocols, and our median first-response time dropped from fourteen hours to under three hours."

A 2025 customer experience benchmarking study by the Molecular Diagnostics Industry Association found that genomics and diagnostics companies with structured VA support for routine inquiry handling achieved Net Promoter Scores an average of 12 points higher than those relying solely on in-house support teams, primarily due to faster response times during peak ordering periods.

Sales Administration: Supporting Commercial Teams at Velocity

Diagnostics sales teams — whether selling to hospital laboratory directors, oncologists, or genetics practices — generate significant administrative demand. Proposal preparation, account documentation, contract submission logistics, implementation onboarding coordination, and billing setup for new institutional accounts all require consistent administrative follow-through that many commercial teams struggle to maintain while simultaneously managing their sales pipelines.

Virtual assistants with diagnostics or life sciences commercial backgrounds are taking on sales administration roles that include CRM data entry and hygiene, quote preparation and tracking, new account onboarding documentation, and sample result reporting coordination for evaluation accounts. These contributions keep sales pipelines clean and allow commercial representatives to stay focused on relationship development and clinical education rather than administrative follow-up.

According to IQVIA's 2026 Diagnostics Commercial Operations Report, diagnostics companies with dedicated administrative support for their field sales teams closed new institutional accounts an average of 24 days faster than those without structured sales support, largely due to faster contract processing and onboarding documentation.

David Laurent, a national accounts director at a pharmacogenomics testing company, described the practical difference: "When I hand an account to ops for onboarding, I need the documentation cycle to start immediately. VA support on the admin side means my new accounts are live in our billing system within a week of signing. That wasn't happening before."

Operational Coordination: Connecting Commercial, Lab, and Clinical Teams

Genomics and diagnostics companies also face significant internal coordination demands at the interface between commercial, laboratory, and clinical teams. Managing the flow of information between sales, lab operations, medical affairs, and billing requires consistent administrative coordination that often falls to project managers or department heads who are already at capacity.

VAs in operational coordination roles at diagnostics companies are supporting cross-functional meeting logistics, internal report distribution, physician portal onboarding follow-up, and insurance coverage update communication to sales teams. These coordination functions are highly routine but require careful attention to accuracy, as errors in insurance coverage information or portal access can directly affect test accessibility for patients.

The Association of Molecular Pathology's 2025 laboratory operations survey noted that administrative coordination gaps at the lab-commercial interface were among the top-five reported causes of order processing delays, suggesting a specific opportunity for structured VA support in that workflow.

Building a VA-Supported Commercial and Service Infrastructure

For genomics and diagnostics companies scaling from early commercial to broader market penetration, the VA model offers a practical way to grow service capacity in proportion to volume without the lag and overhead of sequential full-time hires. The key is defining clear escalation protocols that ensure VAs route complex clinical, legal, or compliance questions to the appropriate internal experts rather than attempting to resolve them independently.

Companies in the genomics and diagnostics space can explore VA partnerships with life sciences-experienced providers like Stealth Agents, which offers customer support, sales coordination, and administrative professionals familiar with the specific demands of molecular testing and diagnostics environments.

The companies that scale their service infrastructure ahead of their volume growth curve will be positioned to capture share during the market's continued expansion without the service quality degradation that reactive staffing invariably produces.

Sources

  • Molecular Diagnostics Industry Association, Customer Experience Benchmarking Study, 2025
  • IQVIA, Diagnostics Commercial Operations Report, 2026
  • Association of Molecular Pathology, Laboratory Operations Survey, 2025